Equities

Ikonisys SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Ikonisys SA

Actions
  • Price (EUR)1.58
  • Today's Change-0.01 / -0.63%
  • Shares traded191.00
  • 1 Year change+5.33%
  • Beta0.6347
Data delayed at least 15 minutes, as of Feb 12 2026 10:21 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ikonisys SA is a France-based that specialize in the design, manufacture and marketing of medical diagnostic equipment. The Company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. It utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. It includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.

  • Revenue in EUR (TTM)617.19k
  • Net income in EUR-2.70m
  • Incorporated2021
  • Employees10.00
  • Location
    Ikonisys SA62 Rue De Caumartin, Paris 9PARIS 75009FranceFRA
  • Phone+33 144710014
  • Websitehttps://ikonisys.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Spineway SA10.99m-1.90m6.20m43.00--0.2598--0.5642-0.0488-0.04880.24510.67130.37390.62053.44224,244.90-6.47-25.14-7.73-30.7671.3376.66-17.29-77.572.04-0.85290.0607--13.6018.9540.63---27.97--
Carmat SA6.97m-51.40m6.36m153.00------0.9128-1.21-1.210.1566-0.77080.1461.401.4845,549.02-107.63-80.36-152.29-100.51-338.50---737.48-2,088.981.01-15.432.46--149.16--4.59--18.44--
Bluelinea SA10.26m-753.92k9.21m79.00--8.9110.110.8974-0.0599-0.05990.81510.05611.040.474412.49115,324.50-7.61-21.89-25.35-51.8498.5494.99-7.35-23.710.3257-7.620.8821---3.888.4221.57--21.85--
Spineguard SA4.32m-2.56m11.65m15.00--1.87--2.69-0.0459-0.04590.07670.06640.49691.444.26196,474.10-29.46-27.72-45.24-47.3970.9873.78-59.29-59.200.8202-5.140.3472--7.77-7.4126.33--10.00--
Laboratoires Euromedis SA38.40m-5.48m12.65m44.00--0.7547--0.3294-1.93-1.9313.515.830.90092.764.01872,683.60-12.988.24-17.9711.7826.7732.38-14.416.092.25-16.410.3414--6.39-14.02-146.59------
Intrasense SA2.65m-6.48m14.18m76.00------5.36-0.1231-0.12310.0503-0.02210.2982--3.2734,815.79-73.01-38.28-205.39-56.1664.1385.39-244.82-85.81---116.176.65---32.04-7.51-58.01--29.78--
Biosynex SA97.95m-70.99m18.94m486.00--0.4186--0.1933-4.31-4.316.162.410.54691.2710.61201,549.40-39.527.98-73.8710.7258.8252.27-72.268.760.4506-11.460.5825--8.8124.20-16.73------
Mauna Kea Technologies SA7.48m-10.39m24.05m61.00------3.22-0.1407-0.14070.1015-0.36890.48541.194.59115,015.40-68.47-47.72---149.1943.2018.06-141.06-129.390.1177--9.54---26.960.5957-179.15---31.06--
Ikonisys SA617.19k-2.70m25.19m10.00--1.05--40.81-0.1334-0.13340.06091.510.02520.81033.4061,719.00-11.01---14.76--0.943---437.39--0.0691-30.680.1686---27.28--7.38------
Implanet SA11.10m-4.81m32.79m44.00------2.95-0.038-0.0380.0876-0.01080.74320.86185.06253,379.00-32.23-37.85-176.46-98.0252.1158.59-43.36-68.070.2485--1.29--26.314.8921.87--25.84--
Diagnostic Medical Systems SA46.77m-1.67m35.98m140.00--2.2539.670.7693-0.069-0.0692.050.60060.8761.844.52324,798.60-2.86-11.47-5.81-20.5239.7938.72-3.27-14.950.6154-0.52030.5811--9.298.2470.50------
Theraclion SA1.90m-5.25m38.29m33.00------20.12-0.1127-0.11270.0408-0.05480.14790.33048.7459,455.31-40.84-33.44-55.80-47.3354.0166.95-276.15-360.911.79-67.332.50---54.44-21.49-56.66---4.97--
AbL Diagnostics SA5.45m463.37k51.57m20.00111.197.4342.819.460.02880.02880.33830.43080.4416--1.60286,763.203.763.595.345.29----8.508.202.91--0.2788---5.03--424.60------
Data as of Feb 12 2026. Currency figures normalised to Ikonisys SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.